Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Aplus Asset Advisor Co. Ltd (244920.KS)
Seoul, KR
Aplus Asset Advisor Co. Ltd offers an extensive array of insurance products, encompassing both life and general coverage. Their diverse portfolio includes health-related policies (such as cancer, medical, nursing, and elderly care), family-focused options (like fetal and child care), and financial planning solutions (including pensions, variable annuities, savings, and variable universal plans). Additionally, they provide property and casualty insurance, covering areas like general indemnity, automobiles, drivers, and fire, among others. Beyond insurance, the company also delivers specialized financial advisory and consulting services. This firm was established in 2007 and conducts its operations from Seoul, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.40% | +6.48% | +4.29% | -20.14% | +89.49% | +20.86% | +114.59% | +143.84% | +29.25% | +62.50% | +62.50% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2025-08 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Insurance - Diversified: +13.4%+32.3% ★ Q1'26: +18.4% (vs Q1'25)
-
EPS growth Insurance - Diversified: +18.0%+897.9% ★ Q1'26: +114.8% (vs Q1'25)
-
FCF margin Insurance - Diversified: +20.2%+3.6% Q1'26: +8.8% (vs Q1'25)
-
EBIT margin Insurance - Diversified: +12.6%+4.2% Q1'26: +9.1% (vs Q1'25)
-
ROIC Insurance - Diversified: +3.8%— Q1'26: +29.0% (vs Q1'25)
-
Share dilution Insurance - Diversified: +0.5%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Insurance - Diversified: 0.00×0.00× ★ Q1'26: 0.63× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. |
|---|---|---|---|---|---|
| Revenue |
270.72B
est: 270.00B (+0.3%)
|
350.87B
est: 305.00B (+15.0%)
|
515.79B
est: 453.10B (+13.8%)
|
682.47B
est: 359.00B (+90.1%)
|
567.40B
567.40B – 567.40B
+58.1% YoY
|
| EBITDA |
104.08B
est: 48.33B (+115.4%)
|
37.13B
est: 54.59B (-32.0%)
|
37.40B
est: 72.66B (-48.5%)
|
53.51B
est: 57.57B (-7.1%)
|
90.99B
90.99B – 90.99B
+58.1% YoY
|
| EBIT |
85.33B
est: 32.20B (+165.0%)
|
17.92B
est: 36.37B (-50.7%)
|
15.77B
est: 47.81B (-67.0%)
|
28.82B
est: 37.88B (-23.9%)
|
59.88B
59.88B – 59.88B
+58.1% YoY
|
| Net Income |
50.33B
est: 47.57B (+5.8%)
|
10.19B
est: 12.07B (-15.6%)
|
2.48B
est: 22.04B (-88.7%)
|
22.12B
est: 26.50B (-16.5%)
|
—
— – —
-100.0% YoY
|
| SGA |
76.92B
est: 111.68B (-31.1%)
|
130.93B
est: 126.16B (+3.8%)
|
210.88B
est: 192.82B (+9.4%)
|
542.60B
est: 152.78B (+255.2%)
|
241.47B
241.47B – 241.47B
+58.1% YoY
|
| EPS |
2,226.05
est: 2,104.00 (+5.8%)
|
451.00
est: 534.00 (-15.5%)
|
109.74
est: 975.00 (-88.7%)
|
978.54
est: 1,172.00 (-16.5%)
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 2/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-10 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Geunho Kwak | Executive Chairman & Chief Executive Officer | 9M | male |
| Daewon Park | MD & Gyeongin Business Division Manager | — | male |
| Gyunam Cho | Vice-Chairman | — | male |
| Jeong-Hyeon Ha | MD & Accounting Officer | — | female |
| Seung Mok Hwang | Chief Executive Officer & Executive Director | — | male |
| Tae-Eop Kwak | MD & Head of Marketing Promotion Headquarters | — | male |
| Yong-Guk Lee | MD & Honam Business Division Manager | — | male |
| Young-Il Jo | Senior Vice President & Gangnam Business Division Manager | — | male |
| Chun-Kyung Lee | President & Strategic Planning Director | — | male |
| Youngha Jeon | President & Head of Management Support Division | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 244920.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
